ValiRx plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was GBP 1.04 million compared to GBP 0.992481 million a year ago. Basic loss per share from continuing operations was GBP 0.0103 compared to GBP 0.0153 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 GBX | +3.64% | -3.39% | -51.69% |
05-20 | London gets boost thanks to rate cut hopes | AN |
05-20 | ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.69% | 4.8M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- VAL Stock
- News ValiRx plc
- ValiRx plc Reports Earnings Results for the Half Year Ended June 30, 2023